Diabetes preceding Parkinson's disease onset. A case-control study

Parkinsonism and Related Disorders

Volumn 15, Issue 9, 2009, Pages 660-664

  D'Amelio, Marco ^a   Ragonese, Paolo ^a   Callari, Graziella ^a   Di Benedetto, Norma ^a   Palmeri, Barbara ^a   Terruso, Valeria ^a   Salemi, Giuseppe ^a   Famoso, Giorgia ^a   Aridon, Paolo ^a   Savettieri, Giovanni ^a  

^a Dipartimento Universitario di Neuroscienze Cliniche   (Italy)

Author keywords

Case control studies; Diabetes; Epidemiology; Parkinson's disease; Risk factors in epidemiology

Indexed keywords

AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; COFFEE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SMOKING HABIT;

CASE-CONTROL STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK FACTORS;

EID: 70350173257     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.02.013     Document Type: Article

References (30)

1. Struck L.K., Rodnitzky R.L., and Dobson J.K. Stroke and its modification in Parkinson's disease. Stroke 21 (1990) 1395-1399
2. Rajput A.H., Offord K.P., Beard C.M., and Kurland L.T. A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology 37 (1987) 226-232
3. Levine R.L., Jones J.C., and Bee N. Stroke and Parkinson's disease. Stroke 23 (1992) 839-842
4. Gorell J.M., Johnson C.C., and Rybicki B.A. Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology 44 (1994) 1865-1868
5. Pressley J.C., Louis E.D., Tang M.X., Cote L., Cohen P.D., Glied S., et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 60 (2003) 87-93
6. Guttman M., Slaughter P.M., Theriault M.E., DeBoer D.P., and Naylor C.D. Parkinsonism in Ontario: comorbidity associated with hospitalization in a large cohort. Mov Disord 19 (2004) 49-53
7. Nataraj A., and Rajput A.H. Parkinson's disease, stroke, and related epidemiology. Mov Disord 20 (2005) 1476-1480
8. Powers K.M., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D., and Checkoway H. Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. Parkinsonism Relat Disord 12 (2006) 185-189
9. Leibson C.L., Maraganore D.M., Bower J.H., Ransom J.E., O'brien P.C., and Rocca W.A. Comorbid conditions associated with Parkinson's disease: a population-based study. Mov Disord 21 (2006) 446-455
10. Scigliano G., Musicco M., Soliveri P., Piccolo I., Ronchetti G., and Girotti F. Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke 37 (2006) 1184-1188
11. Hu G., Jousilahti P., Bidel S., Antikainen R., and Tuomilehto J. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30 (2007) 842-847
12. Arvanitakis Z., Wilson R.S., Bienias J.L., and Bennett D.A. Diabetes and parkinsonian signs in older persons. Alzheimer Dis Assoc Disord 21 (2007) 144-149
13. Simon K.C., Chen H., Schwarzschild M., and Ascherio A. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 69 (2007) 1688-1695
14. Unger J.W., Livingston J.N., and Moss A.M. Insulin receptors in the central nervous system: localization, signaling mechanisms and functional aspects. Prog Neurobiol 36 (1991) 343-352
15. Will J.C., Galuska D.A., Ford E.S., Mokdad A., and Calle E.E. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol 30 (2001) 540-546
16. Quik M. Smoking, nicotine and Parkinson's disease. Trends Neurosci 27 (2004) 561-568
17. Di Monte D., Sandy M.S., Blank L., and Smith M.T. Fructose prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced ATP depletion and toxicity in isolated hepatocytes. Biochem Biophys Res Commun 153 (1988) 734-740
18. Luo S., Liang Y., and Cincotta A.H. Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters. Neuroendocrinology 69 (1999) 160-166
19. Sirtori C.R., Bolme P., and Azarnoff D.L. Metabolic responses to acute and chronic l-DOPA administration in patients with parkinsonism. N Engl J Med 287 (1972) 729-733
20. Ragonese P., D'Amelio M., Salemi G., Aridon P., Gammino M., Epifanio A., et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology 62 (2004) 2010-2014
21. Morgante L., Rocca W.A., Di Rosa A.E., De Domenico P., Grigoletto F., Meneghini F., et al. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 42 (1992) 1901-1907
22. Brocco S., Visentin C., Fedeli U., Schievano E., Avogaro A., Andretta M., et al. Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases. Cardiovasc Diabetol 15 6 (2007) 5 10.1186/1475-2840-6-5
23. Barbeau A. Experience clinique avec le tolbutamide dans la maladie de Parkinson. Union Med Can 90 (1961) 147-151
24. Sandyk R. The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 69 (1993) 125-130
25. Sandyk R., and Awerbuch G.I. The association of diabetes mellitus with dementia in Parkinson's disease. Int J Neurosci 64 (1992) 209-212
26. Kriegsman D.M., Penninx B.W., van Eijk J.T., Boeke A.J., and Deeg D.J. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 49 (1996) 1407-1417
27. Milne J.C., and Denu J.M. The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 12 (2008) 11-17
28. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
29. Dillin A., and Kelly J.W. The yin-yang of sirtuins. Science 317 (2007) 461-462
30. Outeiro T.F., Kontopoulos E., Altmann S.M., Kufareva I., Strathearn K.E., Amore A.M., et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 317 (2007) 516-519